Do you know shwarts
What are you referring to by 'shwarts'?
Surgery
Teach me in detail stomach and pud
| Region | Key Feature |
|---|---|
| Cardia | Attached to esophagus; just proximal is the lower esophageal sphincter |
| Fundus | Superiormost, distensible; bounded by diaphragm above, spleen laterally |
| Body (Corpus) | Contains the majority of parietal (oxyntic) cells |
| Antrum | Distal 25-30% of stomach; begins at the angularis incisura |
| Pylorus | Connects to the proximal duodenum |
| Cell Type | Location | Function |
|---|---|---|
| Surface-foveolar mucous cells | Surface | Secrete neutral glycoprotein + bicarbonate; form protective gel; neutralize HCl |
| Mucous neck cells | Neck of glands | Progenitor for all gastric epithelial cells; also secrete pepsinogens I & II |
| Parietal (oxyntic) cells | Body/Fundus | Secrete HCl and intrinsic factor and bicarbonate |
| Chief cells | Deeper glands | Secrete pepsinogens I & II and lipase |
| Endocrine cells | Throughout | G cells (gastrin), D cells (somatostatin), ECL cells (histamine) |
| Phase | Stimulus | Mechanism |
|---|---|---|
| Cephalic (30%) | Sight, smell, taste, thought of food | Vagal activation β ACh β parietal + G cells |
| Gastric (60%) | Food in stomach | Distension + protein/amino acids β gastrin + ACh |
| Intestinal (10%) | Chyme in duodenum | Peptides stimulate; then acid/fat triggers inhibition |
| Component | Mechanism |
|---|---|
| Mucous layer | Thick gel of glycoproteins; prevents acid from reaching epithelium |
| Bicarbonate secretion | Surface cells secrete HCO3-; maintains pH 7 at cell surface even when lumen is pH 2 |
| Epithelial tight junctions | Prevent back-diffusion of acid |
| Hydrophobic phospholipids | Surface layer repels acid |
| Restitution | Rapid migration of neighboring cells to cover small defects |
| Microcirculation | Reactive hyperemia delivers blood + buffers; removes back-diffused acid |
| Test | Notes |
|---|---|
| Tissue urease test (CLO test) | Biopsy at EGD; fast, sensitive |
| Histology | Biopsy - most definitive |
| Urea breath test | Non-invasive; best for confirming eradication |
| Stool antigen test | Non-invasive; good for diagnosis and confirming eradication |
| Serology (IgG) | Cheap but cannot distinguish active from past infection; not useful post-treatment |
Always test and treat H. pylori when detected. Eradication dramatically reduces ulcer recurrence (see Figure 26-26 in the textbook).
In the US, more than 90% of serious peptic ulcer complications are attributable to H. pylori infection, NSAID use, and/or cigarette smoking.
| Type | Location | Acid Level | H. pylori | Notes |
|---|---|---|---|---|
| I | Lesser curvature, body at incisura | Normal or low | Common | Most common type (60%) |
| II | Body + active duodenal ulcer | High | Common | Combined gastric + duodenal |
| III | Prepyloric | High | Common | Behaves like DU |
| IV | High on lesser curvature near GEJ | Low | Less common | Difficult to resect |
| V | Anywhere; NSAID-induced | Low | Less common | Related to NSAIDs |
| Class | Finding | Rebleed Risk |
|---|---|---|
| Ia | Active spurting | ~90% |
| Ib | Active oozing | ~50% |
| IIa | Visible vessel (non-bleeding) | ~50% |
| IIb | Adherent clot | ~25% |
| IIc | Flat pigmented spot | ~10% |
| III | Clean base | <5% |
| Regimen | Components |
|---|---|
| Clarithromycin triple | PPI (standard or double dose) BD + Clarithromycin 500 mg BD + Amoxicillin 1g BD |
| Metronidazole triple | PPI BD + Metronidazole 500 mg BD + Amoxicillin 1g BD |
| Levofloxacin triple | PPI BD + Amoxicillin 1g BD + Levofloxacin 500 mg OD |
| Sequential therapy | PPI + Amoxicillin (5-7 days), THEN PPI + Clarithromycin + Metronidazole (5-7 days) |
| Bismuth quadruple (salvage) | PPI BD + Bismuth 300mg QID + Tetracycline 500mg QID + Metronidazole 250mg QID |
After H. pylori eradication is confirmed, acid suppression can generally be stopped after 3 months.
Gastric cancer must always be excluded in patients with gastric ulcer or gastric outlet obstruction.
| Operation | Ulcer Recurrence | Mortality | Complications | Notes |
|---|---|---|---|---|
| Parietal cell vagotomy (HSV - Highly Selective Vagotomy) | 5-15% | 0% | Low | Preserves innervation to antrum/pylorus; no drainage needed |
| Truncal vagotomy + pyloroplasty (TV+P) | <10% | <1% | Moderate | Drainage required (vagotomy denervates pylorus) |
| Truncal vagotomy + antrectomy (TV+A) | <2% | 1% | Higher | Most effective at preventing recurrence; removes gastrin source |
| Complication | Mechanism | Treatment |
|---|---|---|
| Dumping syndrome (early) | Rapid emptying of hyperosmolar content into small bowel β fluid shift + release of vasoactive peptides | Small, frequent, dry meals; lie flat after eating; somatostatin analogs |
| Dumping syndrome (late) | Reactive hypoglycemia from excessive insulin response | Small frequent meals; complex carbs; acarbose |
| Diarrhea | Postvagotomy; altered motility; rapid transit | Dietary modification; cholestyramine (if bile diarrhea) |
| Bile reflux gastritis | Loss of pyloric barrier β bile into stomach | PPI, sucralfate; Roux-en-Y conversion |
| Anemia | Iron deficiency (reduced acid for absorption) OR B12 deficiency (lost intrinsic factor) | Iron supplements; B12 injections |
| Weight loss | Small gastric reservoir; rapid transit | Nutritional support |
| Bone disease | Reduced calcium absorption (achlorhydria + rapid transit) | Calcium + Vitamin D supplements |
| Scenario | First-line management |
|---|---|
| Uncomplicated PUD | PPI + H. pylori eradication |
| Bleeding ulcer | IV PPI + resuscitation + urgent endoscopy + endoscopic hemostasis |
| Perforated ulcer | Emergency surgery - Graham patch; consider vagotomy |
| Obstructing ulcer | NG decompression + IV PPI + H. pylori treatment; surgery if no response |
| Intractable ulcer | Rule out ZES/cancer; high-dose PPI; consider surgery |
Good but put more emphasis on initial managment of all complication of pud and definitive treatment there is one table in shwarts
| Complication | Duodenal Ulcer | Gastric Ulcer |
|---|---|---|
| Bleeding | 1. Oversew (emergency) 2. Oversew + V+D 3. V+A (operation of choice in low-risk) | 1. Oversew + biopsy (emergency) 2. Oversew + biopsy + V+D 3. Distal gastrectomy (operation of choice in low-risk) |
| Perforation | 1. Patch (emergency) 2. Patch + HSV 3. Patch + V+D | 1. Biopsy + patch (emergency) 2. Wedge excision + V+D 3. Distal gastrectomy (operation of choice in low-risk) |
| Obstruction | 1. HSV + GJ 2. V+A | 1. Biopsy + HSV + GJ 2. Distal gastrectomy (operation of choice in low-risk) |
| Intractability / Nonhealing | 1. HSV (operation of choice in low-risk) 2. V+D 3. V+A | 1. HSV + wedge excision 2. Distal gastrectomy |
Footnotes from Schwartz:
- Unless the patient is in shock or moribund, a definitive procedure should be considered.
- "Operation of choice in low-risk patient" = the most definitive option listed.
- HSV = Highly Selective Vagotomy | V+A = Vagotomy + Antrectomy | V+D = Vagotomy + Drainage | GJ = Gastrojejunostomy
| Parameter | Points |
|---|---|
| SBP 100-109 mmHg | 1 |
| SBP 90-99 mmHg | 2 |
| SBP <90 mmHg | 3 |
| BUN 6.5-7.9 mmol/L | 2 |
| BUN 8.0-9.9 mmol/L | 3 |
| BUN 10.0-24.9 mmol/L | 4 |
| BUN β₯25 mmol/L | 6 |
| Hb (men) 12.0-12.9 g/dL | 1 |
| Hb (men) 10.0-11.9 g/dL | 3 |
| Hb (men) <10.0 g/dL | 6 |
| Hb (women) 10.0-11.9 g/dL | 1 |
| Hb (women) <10.0 g/dL | 6 |
| Pulse β₯100 bpm | 1 |
| Melena | 1 |
| Syncope | 2 |
| Hepatic disease | 2 |
| Cardiac failure | 2 |
| Forrest Class | Finding | Rebleed Risk | Action |
|---|---|---|---|
| Ia | Active spurting | ~90% | Endoscopic therapy mandatory |
| Ib | Active oozing | ~50% | Endoscopic therapy mandatory |
| IIa | Visible non-bleeding vessel | ~50% | Endoscopic therapy mandatory |
| IIb | Adherent clot | ~25% | Endoscopic therapy + clot removal |
| IIc | Flat pigmented spot | ~10% | Medical therapy; close observation |
| III | Clean base | <5% | Medical therapy; may discharge early |
Mortality for surgery for bleeding peptic ulcer is approximately 20% - reflecting the very high-risk selection of patients who reach the OR today.
Note: Oversewing alone has a higher rebleed rate but lower operative mortality. Definitive operation has lower rebleed rate but higher operative mortality. In the shocked/unstable patient - just oversew. In the stable patient - add vagotomy.
Perforated DU
β
Hemodynamically unstable / Peritonitis >24 hrs old?
YES β Simple Graham Patch closure only
NO β
Chronic ulcer symptoms / Failed medical treatment?
YES β Patch + HSV (or Patch + V+D)
NO β Simple Patch closure (rely on PPI + H. pylori treatment post-op)
There is a clear trend away from definitive operation for perforated duodenal ulcer in the US and Western Europe. Most surgeons rely on Graham patch + postoperative H. pylori eradication + lifelong PPI.
Gastric cancer must always be excluded as a cause of gastric outlet obstruction before assuming it is benign PUD.
| Cause | Key Points |
|---|---|
| Cancer | Gastric cancer, pancreatic cancer, duodenal cancer |
| Persistent H. pylori | Tests may be false-negative; consider empiric re-treatment |
| Noncompliant patient | Not taking PPI, still using NSAIDs surreptitiously |
| Motility disorder | Gastroparesis preventing ulcer healing |
| Zollinger-Ellison syndrome | Gastrinoma causing uncontrolled hypersecretion |
| Complication | First Thing to Do | Key Investigation | Definitive Operation (Low-Risk) |
|---|---|---|---|
| Bleeding | IV resuscitation + IV PPI + urgent EGD | Forrest classification | V+A (DU) / Distal gastrectomy (GU) |
| Perforation | NPO + IV antibiotics + NG tube + upright CXR | CT if CXR negative | Graham patch Β± vagotomy (DU) / Distal gastrectomy (GU) |
| Obstruction | NG decompression + IV fluids + correct electrolytes | Upper GI endoscopy / CT to rule out cancer | V+A (DU) / Distal gastrectomy (GU) |
| Intractability | Stop NSAIDs/smoking, optimize PPI, retest H. pylori, rule out ZES and cancer | Fasting gastrin + EGD with biopsy | HSV (DU) / HSV + wedge excision (GU) |
goodpm students. you wait for me at the library. pls use the time to study and talk with your partner. we will start immediately as soon as i arrive. each pair will have a total of 7 minutes. 2 cases, 4 questions each case. 2.5pts/question, total of 20 points. passing score is 12. during the exam, you can talk to your partner frst before answering. i will accept one answer only and it will be final. so you have to talk and think before giving me the answer. if the time is up and you did not finish the case, grade is automatically zero for the unanswered question. My doc ask questions like this so prepare me
| Question | Key Point to Score Full Marks |
|---|---|
| Q1 | Name the diagnosis + give pathophysiology of why NSAIDs cause it |
| Q2 | NPO + NG + IV fluids + IV PPI + antibiotics + surgical referral |
| Q3 | Graham patch only in unstable patient + justify why no vagotomy |
| Q4 | H. pylori eradicate + stop NSAIDs + lifelong PPI + repeat EGD for gastric ulcer |
| Q5 | Correct diagnosis + interpret vitals as hemodynamic instability + Blatchford score |
| Q6 | Resuscitate + urgent EGD + do NOT permanently stop aspirin in cardiac patient |
| Q7 | Indications for surgery + 3-point ligation of GDA + decision on vagotomy based on stability |
| Q8 | Gastric outlet obstruction + metabolic alkalosis + NG decompression + V+A as definitive |
When do we do ct
| Situation | Do CT? |
|---|---|
| CXR shows free air + classic presentation | β NO - go straight to surgery. CT wastes time. |
| CXR is negative but clinical suspicion is high | β YES - CT abdomen is more sensitive than CXR for pneumoperitoneum |
| Patient is stable, diagnosis uncertain | β YES - CT helps confirm and rules out other causes |
Rule: CXR first. CT only if CXR is negative or diagnosis is unclear. Plain CXR catches ~70% of perforations. CT catches nearly all.
Schwartz states directly: "Usually, significant gastric disease can be diagnosed without these sophisticated imaging studies."
What labs we gonna order for each in initial diagnosis
| Lab | Why |
|---|---|
| CBC / FBC | Hemoglobin level - quantify blood loss; baseline WBC |
| Blood type & crossmatch | Prepare for transfusion immediately |
| BUN / Creatinine | BUN:Creatinine ratio >20:1 = upper GI bleed (blood digested = protein load on kidneys); also assess renal function before scoping |
| Serum electrolytes | Baseline; hypokalemia from vomiting |
| Coagulation (PT/PTT/INR) | Is bleeding worsened by coagulopathy? Is patient on anticoagulants? Must correct before endoscopy |
| Liver function tests | Cirrhosis β varices vs. ulcer? Affects coagulation |
| Platelet count | Thrombocytopenia contributes to bleeding |
| Blood glucose | Baseline |
Exam pearl: Elevated BUN with normal creatinine = upper GI bleed. The blood is digested and absorbed as protein β raises BUN. This is why Blatchford score uses BUN as a parameter.
| Lab | Why |
|---|---|
| CBC / FBC | Leukocytosis = infection/peritonitis; baseline Hb |
| Serum electrolytes | Baseline before surgery; fluid shifts in peritonitis |
| BUN / Creatinine | Renal function - dehydration from fluid loss into peritoneum |
| Serum amylase / lipase | Must rule out acute pancreatitis - also presents with sudden severe epigastric pain. Elevated amylase can also occur in perforation itself (not diagnostic alone) |
| Liver function tests | Baseline pre-op |
| Coagulation (PT/PTT/INR) | Pre-operative requirement |
| Blood glucose | Stress hyperglycemia; baseline |
| Blood type & crossmatch | Pre-operative requirement |
| Blood cultures | If septic / high fever - identify organism |
| Lactate | If patient is in shock - assess severity of tissue hypoperfusion; guides resuscitation |
| ABG (Arterial Blood Gas) | Assess acid-base status in septic/shocked patient |
Exam pearl: Serum amylase is ordered to rule out pancreatitis, but remember - perforation itself can cause a mildly elevated amylase. It does NOT confirm pancreatitis.
| Lab | Why |
|---|---|
| CBC / FBC | Anemia from chronic blood loss; leukocytosis if infected |
| Serum electrolytes | Most important here - classic finding is hypokalemia + hypochloremia from vomiting HCl |
| Serum bicarbonate / ABG | Confirm metabolic alkalosis (HCO3 elevated, pH elevated) from HCl loss |
| BUN / Creatinine | Dehydration β pre-renal AKI is common |
| Blood glucose | Nutritional status + stress |
| Serum albumin / total protein | Nutritional status - obstruction β poor oral intake β malnutrition |
| Liver function tests | Baseline |
| Coagulation | Pre-op requirement if surgery planned |
| Blood type & crossmatch | If surgery anticipated |
Exam pearl: The classic metabolic picture in obstruction is: β Na, β K, β Cl, β HCO3, β pH = Hypochloremic, Hypokalemic Metabolic Alkalosis Caused by repeated vomiting of gastric juice (HCl). The kidney tries to compensate by retaining H+ and excreting K+ β worsens hypokalemia. Fix with normal saline + KCl before any surgery.
| Lab | Why |
|---|---|
| CBC / FBC | Anemia from chronic occult blood loss |
| Serum electrolytes, BUN, Creatinine | Baseline |
| Liver function tests | Baseline |
| Fasting serum gastrin | Most important - rule out Zollinger-Ellison syndrome (ZES). If >1000 pg/mL = virtually diagnostic of gastrinoma. Normal fasting gastrin = <100 pg/mL |
| Serum calcium | ZES associated with MEN-1 (hyperparathyroidism β hypercalcemia) |
| Serum PTH | If calcium elevated - confirm hyperparathyroidism (MEN-1 workup) |
| H. pylori testing | Urea breath test or stool antigen - confirm eradication or persistent infection |
| Serum albumin | Nutritional status before considering surgery |
| Coagulation | Pre-op if surgery planned |
Exam pearl: Always check fasting serum gastrin in any nonhealing ulcer. Stop PPIs for at least 1-2 weeks before testing (PPIs raise gastrin falsely). If fasting gastrin is borderline β do Secretin Stimulation Test (gastrin paradoxically rises in ZES; it stays flat or drops in normal patients).
| Lab | Bleeding | Perforation | Obstruction | Intractability |
|---|---|---|---|---|
| CBC | β | β | β | β |
| Type & Crossmatch | β | β | β if surgery | β if surgery |
| Electrolytes | β | β | β β (key!) | β |
| BUN/Creatinine | β β (key!) | β | β | β |
| Coagulation | β β (key!) | β | β | β |
| Amylase/Lipase | β | β β (rule out panc.) | β | β |
| ABG / Lactate | if shocked | β β (key!) | β (confirm alkalosis) | β |
| Serum Gastrin | β | β | β | β β (key!) |
| Serum Calcium | β | β | β | β (MEN-1) |
| LFTs | β | β | β | β |
| Albumin | β | β | β β (malnutrition!) | β |
| H. pylori test | β | β | β | β β (key!) |
Ok just teach me that table clearly
Rule from Schwartz: "Unless the patient is in shock or moribund, a definitive procedure should be considered."
| Option | Duodenal | Gastric | When |
|---|---|---|---|
| 1 (Emergency) | Oversew | Oversew + Biopsy | Unstable / shocked |
| 2 (Intermediate) | Oversew + V+D | Oversew + Biopsy + V+D | Stable enough for vagotomy |
| 3 (Definitive) | V+A | Distal Gastrectomy | Stable, low-risk patient |
| Option | Duodenal | Gastric | When |
|---|---|---|---|
| 1 (Emergency) | Graham Patch | Biopsy + Patch | Unstable / peritonitis >24hrs |
| 2 (Intermediate) | Patch + HSV | Wedge excision + V+D | Stable, chronic symptoms |
| 3 (Definitive) | Patch + V+D | Distal Gastrectomy | Stable, low-risk patient |
| Option | Duodenal | Gastric | When |
|---|---|---|---|
| 1 | HSV + GJ | Biopsy + HSV + GJ | Can do laparoscopically |
| 2 (Definitive) | V+A | Distal Gastrectomy | Low-risk, standard operation |
| Option | Duodenal | Gastric | When |
|---|---|---|---|
| 1 (Preferred) | HSV | HSV + Wedge excision | Low-risk patient - operation of choice |
| 2 | V+D | - | Moderate risk |
| 3 (Most definitive) | V+A | Distal Gastrectomy | Low-risk, most effective |
| Complication | DUODENAL | GASTRIC |
|---|---|---|
| Bleeding | 1. Oversew 2. Oversew + V+D 3. V+A β | 1. Oversew + Bx 2. Oversew + Bx + V+D 3. Distal Gastrectomy β |
| Perforation | 1. Patch 2. Patch + HSV 3. Patch + V+D β | 1. Bx + Patch 2. Wedge excision + V+D 3. Distal Gastrectomy β |
| Obstruction | 1. HSV + GJ 2. V+A β | 1. Bx + HSV + GJ 2. Distal Gastrectomy β |
| Intractability | 1. HSV β 2. V+D 3. V+A | 1. HSV + Wedge excision 2. Distal Gastrectomy β |
| Abbreviation | Meaning |
|---|---|
| HSV | Highly Selective Vagotomy (preserves antrum innervation - no drainage needed) |
| V+D | Vagotomy + Drainage (truncal vagotomy + pyloroplasty or gastrojejunostomy) |
| V+A | Vagotomy + Antrectomy (most definitive - lowest recurrence <2%) |
| GJ | Gastrojejunostomy (bypass procedure) |
| Bx | Biopsy (mandatory for all gastric ulcers) |
UNSTABLE PATIENT β Always the simplest option (Option 1)
Bleeding β just Oversew
Perforation β just Patch
STABLE / LOW-RISK β Always the definitive option (last option)
Duodenal β V+A (bleeding/perforation/obstruction) or HSV (intractability)
Gastric β Distal Gastrectomy (for all 4 complications)
Gastric ulcer rule: Distal Gastrectomy is the operation of choice in low-risk patients for ALL 4 complications.
Duodenal ulcer rule: V+A is the operation of choice for bleeding, perforation, and obstruction. HSV is preferred for intractability.
When to do egd
Exam rule: Resuscitate FIRST, scope SECOND. But do not delay endoscopy unnecessarily - the longer you wait, the more blood they lose.
Critical rule from Schwartz: "All patients with gastric ulcer diagnosed on upper GI series or found at EGD should have multiple biopsy specimens of the base and rim of the lesion." Duodenal ulcers do NOT routinely need biopsy (malignancy is very rare there).
| Alarm Symptom |
|---|
| Age >55 with new onset dyspepsia |
| Unintentional weight loss |
| Persistent or recurrent vomiting |
| Progressive dysphagia |
| Recent onset odynophagia |
| Unexplained iron deficiency anemia or GI bleeding |
| Palpable abdominal mass or lymphadenopathy |
| Family history of upper GI cancer |
| Complication | Do EGD? | When | Purpose |
|---|---|---|---|
| Bleeding | β YES - urgent | After resuscitation, within 12-24 hrs | Diagnose + treat (hemostasis) + H. pylori biopsy |
| Perforation | β NO acutely | 6-8 weeks post-op | Confirm healing + biopsy |
| Obstruction | β YES | After 48-72 hrs NG decompression | Confirm + biopsy to rule out cancer + balloon dilation |
| Intractability | β YES | At diagnosis + repeat at 6-8 weeks | Multiple biopsies + H. pylori + confirm healing |
| Alarm symptoms | β YES | Immediately | Rule out cancer |
Anatomy Anal Abscess And complications From shwarts detailed
| Feature | ABOVE Dentate Line | BELOW Dentate Line |
|---|---|---|
| Embryological origin | Endoderm (hindgut) | Ectoderm |
| Epithelium | Columnar / transitional | Squamous (anoderm) |
| Sensation | Visceral - poorly localized (pressure only) | Somatic - very sensitive (pain, touch, temp) |
| Arterial supply | Superior rectal artery (from IMA) | Inferior rectal artery (from internal pudendal) |
| Venous drainage | Superior rectal vein β portal system | Inferior rectal vein β internal pudendal β internal iliac (systemic) |
| Lymphatic drainage | Inferior mesenteric nodes + internal iliac nodes | Inguinal lymph nodes (primarily) |
Exam pearl: Cancer above the dentate line β spreads to inferior mesenteric/internal iliac nodes. Cancer below the dentate line β spreads to inguinal nodes. This changes staging and management completely.
Pain pearl: Procedures below the dentate line (e.g., banding hemorrhoids) are VERY painful - need local anesthesia. Procedures above it - much less painful.
| Space | Location | Boundaries | Clinical Importance |
|---|---|---|---|
| Perianal space | Surrounds the anus at skin level | Extends laterally into buttock fat | Most common site of abscess |
| Intersphincteric space | Between IAS and EAS | Continuous with perianal space distally; extends up into rectal wall | Origin of ALL cryptoglandular abscesses |
| Ischiorectal space (fossa) | Lateral & posterior to anus | Medially: EAS; Laterally: ischium; Superiorly: levator ani; Inferiorly: transverse septum | Contains inferior rectal vessels; large potential space |
| Deep postanal space | Posterior, between the two ischiorectal spaces | Above anococcygeal ligament, below levator ani | The two ischiorectal spaces communicate here β horseshoe abscess |
| Supralevator space | Above the levator ani, on either side of rectum | Communicate posteriorly | Abscesses here can mimic intra-abdominal disease |
| Artery | Origin | Supplies |
|---|---|---|
| Superior rectal artery | Terminal branch of IMA | Upper rectum |
| Middle rectal artery | Internal iliac artery | Middle rectum (variable) |
| Inferior rectal artery | Internal pudendal β internal iliac | Anal canal below dentate line; sphincters |
| Location | Drains To |
|---|---|
| Upper + middle rectum | Inferior mesenteric lymph nodes (superiorly) |
| Lower rectum | Inferior mesenteric nodes + internal iliac nodes |
| Anal canal above dentate line | Inferior mesenteric nodes + internal iliac nodes |
| Anal canal below dentate line | Inguinal lymph nodes (primary) |
"The majority of anorectal suppurative disease results from infections of the anal glands (cryptoglandular infection) found in the intersphincteric plane." - Schwartz
| Origin | Drain Via | Why |
|---|---|---|
| Upward extension of intersphincteric abscess | Through the rectum (internally) | Draining externally creates suprasphincteric fistula |
| Upward extension of ischiorectal abscess | Through the ischiorectal fossa (externally) | Draining through rectum creates extrasphincteric fistula |
| Intra-abdominal disease | Most direct route (transabdominal, rectal, or ischiorectal) | Treat the primary cause first |
This is a classic exam question: "Where do you drain a supraelevator abscess?" Answer depends entirely on where it came from.
| Type | Location | Key Feature | Drainage Route |
|---|---|---|---|
| Perianal | Perianal space (skin level) | Visible at anal verge; most common | Local anesthesia in ER; skin incision |
| Ischiorectal | Ischiorectal fossa | Large; may be horseshoe; lateral induration on DRE | Skin incision; horseshoe needs deep postanal + counterincisions |
| Intersphincteric | Between IAS and EAS | No visible swelling; deep pain; needs EUA | Internal (through rectum) - internal sphincterotomy |
| Supraelevator | Above levator ani | Mimics intra-abdominal disease; origin determines drainage | Depends on origin - see above |
"Drainage of an anorectal abscess results in cure for about 50% of patients. The remaining 50% develop a persistent fistula in ano." - Schwartz
| Type | Tract | Frequency | Notes |
|---|---|---|---|
| Intersphincteric | Between IAS and EAS | ~70% | Most common; low risk to sphincter |
| Transsphincteric | Through EAS | ~25% | Passes through external sphincter |
| Suprasphincteric | Over the puborectalis | ~5% | Goes above puborectalis |
| Extrasphincteric | Outside all sphincters | ~1% | Most complex; outside the entire sphincter complex |
Mortality: ~50% despite early recognition and adequate surgery.
ANAL GLAND INFECTION (intersphincteric space)
β
Abscess forms and spreads...
β β β β
Perianal Ischiorectal Intersphincteric Supraelevator
(60%) (20%) (5%) (4%)
Visible Lateral DRE Deep pain Above levator
Drain Drain skin Drain internally Drain = depends on origin
locally Β± horseshoe (sphincterotomy)
β After drainage β
50% cured 50% develop FISTULA IN ANO
β Complications β
Fistula in ano | Recurrence | Fournier's Gangrene | Incontinence
Diagnostic tests we have to order
Create a diagnostic test checklist for anal abscess
Just give in text diagnostics
When will it renew